Home > Insider Trading > Filing (0000950170-24-128986)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899460	Mannkind Corp	MNKD	Pharmaceutical Preparations (2834)	133607736

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1712601	B. Steven Binder	1 Casper Street Danbury CT 06810		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value	Acquisiton	2024-11-15	67,539	$1.47	1,142,565	No	4	M	Direct
Common Stock, $0.01 Par Value	Disposition	2024-11-15	67,539	$6.76	1,075,026	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.01 Par Value	Employee Stock Option (Right to Buy)	Acquisiton	2023-08-07	45,025	$0.00	45,025	$1.47
Common Stock, $0.01 Par Value	Employee Stock Option (Right to Buy)	Disposition	2024-11-15	22,513	$0.00	22,513	$1.47
Common Stock, $0.01 Par Value	Employee Stock Option (Right to Buy)	Disposition	2024-11-15	22,513	$0.00	22,513	$1.47
Common Stock, $0.01 Par Value	Employee Stock Option (Right to Buy)	Disposition	2024-11-15	22,513	$0.00	22,513	$1.47
Common Stock, $0.01 Par Value	Deferred Restricted Stock Unit	Acquisiton	2024-11-18	17,575	$0.00	17,575	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
45,025	2023-08-07	2027-08-24	No	4	A	Direct
22,512	2018-08-02	2027-08-24	No	4	M	Direct
22,512	2020-02-25	2027-08-24	No	4	M	Direct
22,512	2023-08-07	2027-08-24	No	4	M	Direct
17,575			No	4	A	Direct

Footnotes

Transaction occurred pursuant to Rule 10b5-1 Plan established August 16, 2024.
The weighted average sales price of the reported transaction was $6.76 based on a range of prices between $6.63 and $7.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 7, 2023, one of the defined performance milestones was met, resulting in the vesting of the option.
Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.
Restricted stock unit vested on November 18, 2024, but the shares will not be delivered until there is a separation of service from the board of directors of MannKind Corporation.